Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 63

    1.

    Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category.

    Polis AB, Abate N, Catapano AL, Ballantyne CM, Davidson MH, Smugar SS, Tershakovec AM.

    Metab Syndr Relat Disord. 2009 Nov 24. [Epub ahead of print]PMID: 19929597 [PubMed - as supplied by publisher]

    4.

    Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo.

    Bingham CO 3rd, Smugar SS, Wang H, Tershakovec AM.

    Rheumatology (Oxford). 2009 Sep;48(9):1122-7. Epub 2009 Jul 9.PMID: 19589894 [PubMed - indexed for MEDLINE]Related articles

    5.

    Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).

    Robinson JG, Ballantyne CM, Grundy SM, Hsueh WA, Parving HH, Rosen JB, Adewale AJ, Polis AB, Tomassini JE, Tershakovec AM.

    Am J Cardiol. 2009 Jun 15;103(12):1694-702.PMID: 19539078 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.

    Tomassini JE, Mazzone T, Goldberg RB, Guyton JR, Weinstock RS, Polis A, Jensen E, Tershakovec AM.

    Diabetes Obes Metab. 2009 Sep;11(9):855-64. Epub 2009 Jun 5.PMID: 19508464 [PubMed - in process]Related articles

    7.

    Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.

    Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM.

    Am J Cardiol. 2009 Feb 1;103(3):369-74. Epub 2008 Oct 30.PMID: 19166691 [PubMed - indexed for MEDLINE]Related articles

    8.

    Progress and controversies: treating obesity and insulin resistance in the context of hypertension.

    McGill JB, Haffner S, Rees TJ, Sowers JR, Tershakovec AM, Weber M.

    J Clin Hypertens (Greenwich). 2009 Jan;11(1):36-41. Review.PMID: 19125857 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.

    Leiter LA, Bays H, Conard S, Bird S, Rubino J, Hanson ME, Tomassini JE, Tershakovec AM.

    Am J Cardiol. 2008 Dec 1;102(11):1495-501. Epub 2008 Oct 23.PMID: 19026303 [PubMed - indexed for MEDLINE]Related articles

    10.

    Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.

    Conard SE, Bays HE, Leiter LA, Bird SR, Rubino J, Lowe RS, Tomassini JE, Tershakovec AM.

    Am J Cardiol. 2008 Dec 1;102(11):1489-94. Epub 2008 Oct 23.PMID: 19026302 [PubMed - indexed for MEDLINE]Related articles

    11.

    Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.

    Bingham CO 3rd, Bird SR, Smugar SS, Xu X, Tershakovec AM.

    Osteoarthritis Cartilage. 2008 Nov;16(11):1289-93. Epub 2008 Jun 2.PMID: 18514551 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.

    Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.

    J Am Coll Cardiol. 2008 Apr 22;51(16):1564-72.PMID: 18420099 [PubMed - indexed for MEDLINE]Related articles

    13.

    Ezetimibe: cholesterol lowering and beyond.

    Bays HE, Neff D, Tomassini JE, Tershakovec AM.

    Expert Rev Cardiovasc Ther. 2008 Apr;6(4):447-70. Review.PMID: 18402536 [PubMed - indexed for MEDLINE]Related articles

    14.

    A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.

    Oparil S, Abate N, Chen E, Creager MA, Galet V, Jia G, Julius S, Lerman A, Lyle PA, Pool J, Tershakovec AM.

    Curr Med Res Opin. 2008 Apr;24(4):1101-14. Epub 2008 Mar 6.PMID: 18328120 [PubMed - indexed for MEDLINE]Related articles

    15.

    Correlation of measures of pain, function, and overall response: results pooled from two identical studies of etoricoxib in chronic low back pain.

    Sheldon EA, Bird SR, Smugar SS, Tershakovec AM.

    Spine (Phila Pa 1976). 2008 Mar 1;33(5):533-8.PMID: 18317199 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study.

    Tershakovec AM, Keane WF, Zhang Z, Lyle PA, Appel GB, McGill JB, Parving HH, Cooper ME, Shahinfar S, Brenner BM.

    Diabetes Care. 2008 Mar;31(3):445-7. Epub 2007 Dec 10.PMID: 18070995 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A double-blind randomized controlled trial of rofecoxib and multidose oxycodone/acetaminophen in dental impaction pain.

    Desjardins PJ, Black PM, Daniels SE, Bird SR, Petruschke RA, Chang DJ, Smugar SS, Tershakovec AM.

    J Oral Maxillofac Surg. 2007 Aug;65(8):1624-32. No abstract available. PMID: 17656293 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout.

    Navarra S, Rubin BR, Yu Q, Smugar SS, Tershakovec AM.

    Curr Med Res Opin. 2007 Jul;23(7):1685-91.PMID: 17588299 [PubMed - indexed for MEDLINE]Related articles

    19.

    The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain.

    Chelly JE, Nissen CW, Rodgers AJ, Smugar SS, Tershakovec AM.

    Curr Med Res Opin. 2007 Jan;23(1):195-206.PMID: 17207303 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.

    Goldberg RB, Guyton JR, Mazzone T, Weinstock RS, Polis A, Edwards P, Tomassini JE, Tershakovec AM.

    Mayo Clin Proc. 2006 Dec;81(12):1579-88. Erratum in: Mayo Clin Proc. 2007 Mar;82(3):387. PMID: 17165637 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome.

    Denke M, Pearson T, McBride P, Gazzara RA, Brady WE, Tershakovec AM.

    Diab Vasc Dis Res. 2006 Sep;3(2):93-102.PMID: 17058629 [PubMed - indexed for MEDLINE]Related articles

    22.

    Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.

    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.

    Curr Med Res Opin. 2006 Oct;22(10):2041-53.PMID: 17022864 [PubMed - indexed for MEDLINE]Related articles

    24.

    Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.

    Bingham CO 3rd, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM.

    Rheumatology (Oxford). 2007 Mar;46(3):496-507. Epub 2006 Aug 27.PMID: 16936327 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.

    Smugar SS, Schnitzer TJ, Weaver AL, Rubin BR, Polis AB, Tershakovec AM.

    Curr Med Res Opin. 2006 Jul;22(7):1353-67.PMID: 16834834 [PubMed - indexed for MEDLINE]Related articles

    26.

    Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone.

    Weaver AL, Messner RP, Storms WW, Polis AB, Najarian DK, Petruschke RA, Geba GP, Tershakovec AM.

    J Clin Rheumatol. 2006 Feb;12(1):17-25.PMID: 16484875 [PubMed - indexed for MEDLINE]Related articles

    27.

    Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.

    Birbara C, Ruoff G, Sheldon E, Valenzuela C, Rodgers A, Petruschke RA, Chang DJ, Tershakovec AM.

    Curr Med Res Opin. 2006 Jan;22(1):199-210.PMID: 16393445 [PubMed - indexed for MEDLINE]Related articles

    28.

    Calcium and dairy intake and measures of obesity in hyper- and normocholesterolemic children.

    Dixon LB, Pellizzon MA, Jawad AF, Tershakovec AM.

    Obes Res. 2005 Oct;13(10):1727-38.PMID: 16286520 [PubMed - indexed for MEDLINE]Related articles

    29.

    Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

    Kjeldsen SE, Lyle PA, Tershakovec AM, Devereux RB, Oparil S, Dahlöf B, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Wedel H.

    Expert Opin Emerg Drugs. 2005 Nov;10(4):729-45. Review.PMID: 16262560 [PubMed - indexed for MEDLINE]Related articles

    30.

    Psychological considerations in pediatric weight management.

    Tershakovec AM.

    Obes Res. 2004 Oct;12(10):1537-8. No abstract available. PMID: 15536216 [PubMed - indexed for MEDLINE]Related articles

    31.

    Obesity during childhood and adolescence augments bone mass and bone dimensions.

    Leonard MB, Shults J, Wilson BA, Tershakovec AM, Zemel BS.

    Am J Clin Nutr. 2004 Aug;80(2):514-23.PMID: 15277178 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Prediction equations for resting energy expenditure in overweight and normal-weight black and white children.

    McDuffie JR, Adler-Wailes DC, Elberg J, Steinberg EN, Fallon EM, Tershakovec AM, Arslanian SA, Delany JP, Bray GA, Yanovski JA.

    Am J Clin Nutr. 2004 Aug;80(2):365-73.PMID: 15277157 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    HIV-related lipodystrophy and related factors.

    Tershakovec AM, Frank I, Rader D.

    Atherosclerosis. 2004 May;174(1):1-10. Review.PMID: 15135244 [PubMed - indexed for MEDLINE]Related articles

    34.

    Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial.

    Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL.

    JAMA. 2003 Apr 9;289(14):1805-12.PMID: 12684359 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Acupuncture for the treatment of obesity: a review of the evidence.

    Lacey JM, Tershakovec AM, Foster GD.

    Int J Obes Relat Metab Disord. 2003 Apr;27(4):419-27. Review.PMID: 12664074 [PubMed - indexed for MEDLINE]Related articles

    36.

    Body composition and metabolic factors in obese children and adolescents.

    Tershakovec AM, Kuppler KM, Zemel BS, Katz L, Weinzimer S, Harty MP, Stallings VA.

    Int J Obes Relat Metab Disord. 2003 Jan;27(1):19-24.PMID: 12532149 [PubMed - indexed for MEDLINE]Related articles

    37.

    Ethnicity, insurance type, and follow-up in a pediatric weight management program.

    Tershakovec AM, Kuppler K.

    Obes Res. 2003 Jan;11(1):17-20.PMID: 12529480 [PubMed - indexed for MEDLINE]Related articles

    38.

    Persistent hypercholesterolemia is associated with the development of obesity among girls: the Bogalusa Heart Study.

    Tershakovec AM, Jawad AF, Stouffer NO, Elkasabany A, Srinivasan SR, Berenson GS.

    Am J Clin Nutr. 2002 Oct;76(4):730-5.PMID: 12324284 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Age, sex, ethnicity, body composition, and resting energy expenditure of obese African American and white children and adolescents.

    Tershakovec AM, Kuppler KM, Zemel B, Stallings VA.

    Am J Clin Nutr. 2002 May;75(5):867-71.PMID: 11976160 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Diet quality of young children who received nutrition education promoting lower dietary fat.

    Dixon LB, Tershakovec AM, McKenzie J, Shannon B.

    Public Health Nutr. 2000 Dec;3(4):411-6.PMID: 11135795 [PubMed - indexed for MEDLINE]Related articles

    41.

    Early risk factors for increased adiposity: a cohort study of African American subjects followed from birth to young adulthood.

    Stettler N, Tershakovec AM, Zemel BS, Leonard MB, Boston RC, Katz SH, Stallings VA.

    Am J Clin Nutr. 2000 Aug;72(2):378-83.PMID: 10919930 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Resting energy expenditure and prediction equations in young children with failure to thrive.

    Sentongo TA, Tershakovec AM, Mascarenhas MR, Watson MH, Stallings VA.

    J Pediatr. 2000 Mar;136(3):345-50.PMID: 10700691 [PubMed - indexed for MEDLINE]Related articles

    43.

    Nutrition interventions in childhood for the prevention of chronic diseases in adulthood.

    Mascarenhas MR, Tershakovec AM, Stettler N.

    Curr Opin Pediatr. 1999 Dec;11(6):598-604. Review.PMID: 10590923 [PubMed - indexed for MEDLINE]Related articles

    44.

    Onset of adolescent eating disorders. Dieting may be an early sign, rather than a cause, of eating disorder.

    Stettler N, Tershakovec AM, Leonard MB.

    BMJ. 1999 Jun 26;318(7200):1761-2. No abstract available. PMID: 10381722 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Insurance reimbursement for the treatment of obesity in children.

    Tershakovec AM, Watson MH, Wenner WJ Jr, Marx AL.

    J Pediatr. 1999 May;134(5):573-8.PMID: 10228292 [PubMed - indexed for MEDLINE]Related articles

    46.

    Psychosocial factors in nutrition education for hypercholesterolemic children.

    McHale SM, Tershakovec AM, Corneal DA, Tournier BA, Shannon BM.

    Ann Behav Med. 1998 Summer;20(3):233-40.PMID: 9989332 [PubMed - indexed for MEDLINE]Related articles

    47.

    Intravenous amino acids, cholestasis and kwashiorkor.

    Shamir R, Tershakovec AM, Barsky DL.

    J Med. 1998;29(1-2):37-44.PMID: 9704291 [PubMed - indexed for MEDLINE]Related articles

    48.

    Growth of hypercholesterolemic children completing physician-initiated low-fat dietary intervention.

    Tershakovec AM, Jawad AF, Stallings VA, Zemel BS, McKenzie JM, Stolley PD, Shannon BM.

    J Pediatr. 1998 Jul;133(1):28-34.PMID: 9672506 [PubMed - indexed for MEDLINE]Related articles

    49.

    Long-term growth and development in children after home parental nutrition.

    Leonberg BL, Chuang E, Eicher P, Tershakovec AM, Leonard L, Stallings VA.

    J Pediatr. 1998 Mar;132(3 Pt 1):461-6.PMID: 9544902 [PubMed - indexed for MEDLINE]Related articles

    50.

    Age-related changes in cardiovascular disease risk factors of hypercholesterolemic children.

    Tershakovec AM, Jawad AF, Stallings VA, Cortner JA, Zemel BS, Shannon BM.

    J Pediatr. 1998 Mar;132(3 Pt 1):414-20.PMID: 9544893 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...